| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/30/2012 | CN102475888A 皮肤用含有辅料的药物微粒与含有辅料的水的透皮吸收药物 Skin with drug particles contain adjuvants and excipients containing water transdermal drug absorption |
| 05/30/2012 | CN102100665B Eye drops containing vitamin E derivatives and preparation method thereof |
| 05/30/2012 | CN101678113B Low-molecule drug-containing nanoparticle having sustained release negatively charged group |
| 05/30/2012 | CN101653416B Tumor dual target liposome mediated by integrin and preparation method thereof |
| 05/30/2012 | CN101622012B Improved medicinal compositions comprising buprenorphine and nalmefene |
| 05/30/2012 | CN101573361B Novel aminopyrimidine derivative as plk1 inhibitor |
| 05/30/2012 | CN101433716B Composition for treating malignant solid tumors and preparation thereof and use |
| 05/30/2012 | CN101081224B Stable extended release oral dosage composition |
| 05/30/2012 | CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 05/29/2012 | US8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 05/29/2012 | US8188151 Methods for treating diabetes |
| 05/29/2012 | US8188118 Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies |
| 05/29/2012 | US8188108 Pharmaceutical composition |
| 05/29/2012 | US8188107 T-614 is a cyclooxygenase-2 inhibitor; reduced plasma concentrations of an opioid analgesic, while still providing effective pain management; side effect reduction |
| 05/29/2012 | US8188066 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 05/29/2012 | US8187630 Extended release oral dosage composition |
| 05/29/2012 | US8187614 Method of using lectins for prevention and treatment of oral and alimentary tract disorders |
| 05/29/2012 | US8187597 Combination therapy for the treatment of ocular neovascular disorders |
| 05/29/2012 | US8187590 Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/29/2012 | CA2554751C Anti-inflammatory analgesic for external use |
| 05/29/2012 | CA2541109C Composition for the activation of the immune system |
| 05/29/2012 | CA2534241C Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 05/29/2012 | CA2512487C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 05/29/2012 | CA2496127C Piperidinyl compounds that selectively bind integrins |
| 05/29/2012 | CA2495350C Use of lck inhibitor for treatment of immunologic diseases |
| 05/29/2012 | CA2487846C Method, composition and kit for antigenic binding of norwalk-like viruses |
| 05/29/2012 | CA2478616C Use of adenoviruses mutated in the va genes for cancer treatment |
| 05/29/2012 | CA2446738C Abuse-resistant opioid dosage form |
| 05/29/2012 | CA2403817C Methods of modulating hair growth |
| 05/29/2012 | CA2343579C Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/29/2012 | CA2280736C Methods for modulating hematopoiesis and vascular growth |
| 05/24/2012 | WO2012068282A1 Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 05/24/2012 | WO2012068032A1 Fgfr1 extracellular domain combination therapies |
| 05/24/2012 | WO2012065201A1 Composition comprising a peptide and an inhibitor of viral neuraminidase |
| 05/24/2012 | WO2012038333A3 Composition to act in prevention and to take care of diabetic foot |
| 05/24/2012 | WO2012028963A3 Compositions including a sodium channel blocker (lamotrigine) and a b vitamin molecule (folate) for use in treating a psychological, a neurological, a neurodegenerative disorder, and a disorder involving pain |
| 05/24/2012 | WO2011119288A3 Multilayer melt-extruded film |
| 05/24/2012 | US20120129887 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 05/24/2012 | US20120129823 Contraception process and administration form for the same |
| 05/24/2012 | US20120129777 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides |
| 05/24/2012 | US20120129178 Genomic polymorphism for predicting therapeutic response |
| 05/24/2012 | US20120128715 Method for stimulating the immune response of newborns |
| 05/24/2012 | US20120128647 Delivery of compounds with rehydrated blood cells |
| 05/24/2012 | US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof |
| 05/24/2012 | CA2817846A1 Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 05/24/2012 | CA2817840A1 Antiviral compounds |
| 05/24/2012 | CA2817787A1 Composition comprising a peptide and an inhibitor of viral neuraminidase |
| 05/24/2012 | CA2817537A1 Fgfr1 extracellular domain combination therapies |
| 05/23/2012 | EP2455103A1 Anti-cancer agent, method for inducing apoptosis of cancer cells, and method for screening for anti-cancer agent |
| 05/23/2012 | EP2455086A1 Use of chitosans for the treatment of nail inflammatory diseases |
| 05/23/2012 | EP2453922A1 Antibacterial oral composition |
| 05/23/2012 | EP2453912A1 Process and composition for treatment of canine and human leishmaniasis |
| 05/23/2012 | EP2453897A1 Combination of a sodium-proton exchanger inhibitor and of a dihydro-1,3,5-triazine amine derivative |
| 05/23/2012 | EP2453895A1 (+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 05/23/2012 | EP2453890A1 Compositions comprising a cholinesterase inhibitor for treating cognitive disorders |
| 05/23/2012 | EP2453888A1 Use of at least one omega-3 fatty acid and of at least one polyphenol for the endogenous synthesis of eicosapentanoic acid and docosahexanoic acid |
| 05/23/2012 | EP2453887A1 Use of pro-inflammatory compounds for promoting bone formation |
| 05/23/2012 | EP2453746A1 Tazarotene derivatives |
| 05/23/2012 | EP1806151B1 Drug for external use and adhesive patch |
| 05/23/2012 | EP1660057B1 Combination therapy for the treatment of ocular neovascular disorders |
| 05/23/2012 | EP1346059B1 Photochemical internalization for delivery of molecules into the cytosol |
| 05/23/2012 | CN102471300A 用于增强病毒效力的组合物和方法 Compositions and methods for enhancing the effectiveness of the virus |
| 05/23/2012 | CN102470174A 抗癌剂、癌细胞的凋亡诱导方法及抗癌剂的筛选方法 Anticancer agent, apoptosis-inducing anticancer agent and a method of cancer screening method |
| 05/23/2012 | CN102470165A Preparation comprising insulin, nicotinamide and an amino acid |
| 05/23/2012 | CN102470138A 钠-质子交换蛋白抑制剂和二氢-1,3,5-三嗪胺衍生物的组合产品 Sodium - proton exchange inhibitors dihydro-1,3,5-triazine and the amine derivative of combination products |
| 05/23/2012 | CN102470126A 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂 Acid pump for the treatment of diseases related to abnormal bowel movements antagonist |
| 05/23/2012 | CN102470119A L-丝氨酸作为药物用于预防和/或治疗皮肤炎症应答的用途 L- serine as a medicament for the prophylaxis and / or treatment of skin inflammation response |
| 05/23/2012 | CN102470118A External preparation containing nsaids and method for producing the external preparation |
| 05/23/2012 | CN102464874A 星型多臂plga/peg两亲性嵌段共聚物及其应用 Star Dobby plga / peg amphiphilic block copolymer and its application |
| 05/23/2012 | CN102462843A 用于抑制发炎的医药组合物 For inhibiting inflammatory pharmaceutical compositions |
| 05/23/2012 | CN101948539B IL-18 binding proteins |
| 05/23/2012 | CN101804197B Medicament compound for treating cancer bone metastasis and purposes thereof |
| 05/23/2012 | CN101686962B Anthelmintic combination |
| 05/23/2012 | CN101642573B Chitosan-based hepatic-targeted nano-particle drug delivery system and preparation method thereof |
| 05/23/2012 | CN101199848B Drug compound for Ca channel retarder/diuretic/ folate coupling and function |
| 05/23/2012 | CN101103013B 1-thio-D-glucitol derivatives |
| 05/22/2012 | US8183295 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/22/2012 | US8183273 Bicyclic compound, production and use thereof |
| 05/22/2012 | US8183226 Myocardial perfusion imaging method |
| 05/22/2012 | US8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators |
| 05/22/2012 | US8183208 Targeted delivery of drugs for the treatment of viral infections |
| 05/22/2012 | US8183206 Particularly 3-methyl-1-phenyl-2-pyrazolin-5-one; thrombolytic agent, an anticoagulant and/or a platelet aggregation inhibitory agent such as a thromboxane synthetase inhibitor; for treating and/or preventing ischemic diseases which are safe and have few side effects |
| 05/22/2012 | US8183009 Assaying cellular markers for the evaluation of tumors |
| 05/22/2012 | US8182846 Plant extracts and uses thereof |
| 05/22/2012 | US8182837 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness |
| 05/22/2012 | US8182527 Heparin barrier coating for controlled drug release |
| 05/22/2012 | CA2536135C Multivitamin syrup for children or young adults |
| 05/22/2012 | CA2491296C Methods for treating psychosis associated with interferon-.alpha. therapy |
| 05/22/2012 | CA2459033C Methods for inhibiting cognitive deterioration in adults with down's syndrome |
| 05/22/2012 | CA2440214C Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/22/2012 | CA2406024C Methods for improving size and appearance of a wound |
| 05/22/2012 | CA2399918C Water containing soluble fiber |
| 05/18/2012 | WO2012065086A1 Conjugates of an il-2 moiety and a polymer |
| 05/18/2012 | WO2012065057A2 Phosphatidylinositol 3-kinase inhibitors and methods of their use |
| 05/18/2012 | WO2012065019A2 Pyridopyrimidinone inhibitors of p13k alpha |
| 05/18/2012 | WO2012064307A1 Pharmaceutical compositions comprising rosuvastatin |
| 05/18/2012 | WO2012063513A1 Method of treatment for mental disorders |
| 05/18/2012 | WO2012063217A1 Composition for treating phonatory and olfactory apparatus disorders |
| 05/18/2012 | WO2012062920A1 Combination therapy with an antitumor alkaloid |
| 05/18/2012 | WO2012062694A1 Use of 2-carboxamide cycloamino urea derivatives in the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |